Suppr超能文献

肢端肥大症中垂体神经内分泌肿瘤T2信号强度的定量和定性评估——呼吁统一

Quantitative and qualitative assessment of a pituitary neuroendocrine tumor's T2-signal intensity in acromegaly - a call for unification.

作者信息

Godlewska-Nowak Magdalena, Grochowska Anna, Zieliński Grzegorz, Bogusławska Anna, Adamek Dariusz, Maksymowicz Maria, Hubalewska-Dydejczyk Alicja, Gilis-Januszewska Aleksandra

机构信息

Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland.

Doctoral School of Medical and Health Sciences, Jagiellonian University, Krakow, Poland.

出版信息

Front Endocrinol (Lausanne). 2024 Nov 20;15:1441745. doi: 10.3389/fendo.2024.1441745. eCollection 2024.

Abstract

INTRODUCTION

The T2-signal intensity (SI) of somatotroph pituitary neuroendocrine tumors (sPitNET) is associated with treatment response and granulation pattern. Our aim was to evaluate SI assessment methods and their clinical implications, including responsiveness to preoperative first-generation somatostatin analogs (SSA).

METHODS

This single-center, observational study included unselected, consecutive patients with newly diagnosed acromegaly. Out of 109 treatment-naïve patients, 69 were eligible. The qualitative Visual Method involved a visual comparison of the sPitNET with the temporal gray matter. The Three Tissue Method compared the quantified SI of the sPitNET, temporal white matter, and gray matter. The signal intensity ratio of the sPitNET vs. gray matter (GM-SIR) was calculated. Tumors were divided into three groups: hyperintense (HYPER), isointense (ISO), and hypointense (HYPO) according to the Visual Method, Three Tissue Method, and GM-SIR. These groups were compared in terms of demographic, radiological, and biochemical features. The SI assessment methods were investigated for their ability to predict preoperative SSA responsiveness.

RESULTS

SI assessment methods classified SI type correspondingly in 58-75.4% of cases. ISO constituted 39-49% of the analyzed sPitNETs. All methods identified significant differences in tumor volume between the SI groups, with HYPO being more biochemically active per tumor volume unit. According to the Three Tissue Method, patients with ISO had the youngest age at diagnosis and onset. According to the Visual Method, ISO had a lower chance of achieving insulin-like growth factor 1 (IGF1) normalization compared to HYPO (odds ratio (OR) 0.089, confidence interval (CI) 0.015-0.538, p= 0.008)), with no differences between HYPER and HYPO. Only the Visual Method predicted the IGF1 normalization after SSA. HYPER and ISO sPitNETs were classified in electron microscopy as both densely and sparsely granulated. Bihormonal tumors presented only as HYPO and ISO. According to the Three Tissue Method, no HYPO was diagnosed with sparse granulation.

DISCUSSION

We demonstrated discrepancies between the SI assessment methods. The Visual Method predicted the outcome of preoperative treatment with SSA. Clinically, ISO behaved similarly to HYPER. Further studies are needed to unify SI assessment and improve its clinical applicability in acromegaly.

摘要

引言

生长激素垂体神经内分泌肿瘤(sPitNET)的T2信号强度(SI)与治疗反应及颗粒化模式相关。我们的目的是评估SI评估方法及其临床意义,包括对术前第一代生长抑素类似物(SSA)的反应性。

方法

这项单中心观察性研究纳入了未经选择的、连续的新诊断肢端肥大症患者。在109例未经治疗的患者中,69例符合条件。定性视觉方法涉及将sPitNET与颞叶灰质进行视觉比较。三组织方法比较了sPitNET、颞叶白质和灰质的量化SI。计算sPitNET与灰质的信号强度比(GM-SIR)。根据视觉方法、三组织方法和GM-SIR,将肿瘤分为三组:高信号(HYPER)、等信号(ISO)和低信号(HYPO)。对这些组在人口统计学、放射学和生化特征方面进行比较。研究SI评估方法预测术前SSA反应性的能力。

结果

SI评估方法在58%-75.4%的病例中相应地对SI类型进行了分类。ISO占分析的sPitNET的39%-49%。所有方法均发现SI组之间肿瘤体积存在显著差异,每个肿瘤体积单位中HYPO的生化活性更高。根据三组织方法,ISO患者诊断和发病时年龄最小。根据视觉方法,与HYPO相比,ISO达到胰岛素样生长因子1(IGF1)正常化的机会较低(优势比(OR)0.089,置信区间(CI)0.015-0.538,p = 0.008)),HYPER与HYPO之间无差异。只有视觉方法预测了SSA治疗后IGF1的正常化。HYPER和ISO的sPitNET在电子显微镜下分类为密集颗粒型和稀疏颗粒型。双激素肿瘤仅表现为HYPO和ISO。根据三组织方法,未诊断出稀疏颗粒型的HYPO。

讨论

我们证明了SI评估方法之间存在差异。视觉方法预测了术前SSA治疗的结果。临床上,ISO的表现与HYPER相似。需要进一步研究以统一SI评估并提高其在肢端肥大症中的临床适用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaf/11618535/d15b22e9d9f7/fendo-15-1441745-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验